MicroRNA Library-Based Functional Screening Identified Androgen-Sensitive miR-216a as a Player in Bicalutamide Resistance in Prostate Cancer
暂无分享,去创建一个
Koji Okamoto | Satoshi Inoue | Kazuhiro Ikeda | K. Horie-Inoue | S. Inoue | K. Okamoto | K. Ikeda | T. Miyazaki | Toshiaki Miyazaki | Wataru Sato | Kuniko Horie-Inoue | W. Sato | Wataru Sato | Kuniko Horie-Inoue
[1] F. S. French,et al. Androgen receptor stabilization in recurrent prostate cancer is associated with hypersensitivity to low androgen. , 2001, Cancer research.
[2] Tao Zhang,et al. Androgen receptor remains critical for cell-cycle progression in androgen-independent CWR22 prostate cancer cells. , 2006, The American journal of pathology.
[3] A. Vis,et al. Key targets of hormonal treatment of prostate cancer. Part 1: the androgen receptor and steroidogenic pathways , 2009, BJU international.
[4] David J. Arenillas,et al. JASPAR 2014: an extensively expanded and updated open-access database of transcription factor binding profiles , 2013, Nucleic Acids Res..
[5] M. Kruhøffer,et al. miR-345 in Metastatic Colorectal Cancer: A Non-Invasive Biomarker for Clinical Outcome in Non-KRAS Mutant Patients Treated with 3rd Line Cetuximab and Irinotecan , 2014, PloS one.
[6] K. Horie-Inoue,et al. MicroRNA-574-3p, identified by microRNA library-based functional screening, modulates tamoxifen response in breast cancer , 2015, Scientific Reports.
[7] E. Antonarakis,et al. Novel targeted therapeutics for metastatic castration-resistant prostate cancer. , 2010, Cancer letters.
[8] C. Croce,et al. MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review , 2012, EMBO molecular medicine.
[9] R. Vessella,et al. Molecular determinants of resistance to antiandrogen therapy , 2004, Nature Medicine.
[10] F. S. French,et al. A mechanism for androgen receptor-mediated prostate cancer recurrence after androgen deprivation therapy. , 2001, Cancer research.
[11] K. Pienta,et al. A hierarchical network of transcription factors governs androgen receptor-dependent prostate cancer growth. , 2007, Molecular cell.
[12] Karen E. Knudsen,et al. AR, the cell cycle, and prostate cancer , 2008, Nuclear Receptor Signaling.
[13] H. Frierson,et al. Activation of Akt Signaling in Prostate Induces a TGFβ Mediated Restraint on Cancer Progression and Metastasis , 2013, Oncogene.
[14] Chang-Zheng Chen,et al. MicroRNAs as oncogenes and tumor suppressors. , 2005, The New England journal of medicine.
[15] A. Tesei,et al. Prolonged exposure to (R)-bicalutamide generates a LNCaP subclone with alteration of mitochondrial genome , 2014, Molecular and Cellular Endocrinology.
[16] A. Morin,et al. SIRNA-Directed In Vivo Silencing of Androgen Receptor Inhibits the Growth of Castration-Resistant Prostate Carcinomas , 2007, PloS one.
[17] N. Seki,et al. Novel oncogenic function of mesoderm development candidate 1 and its regulation by MiR-574-3p in bladder cancer cell lines , 2011, International journal of oncology.
[18] H. Klocker,et al. Androgen receptor down regulation by small interference RNA induces cell growth inhibition in androgen sensitive as well as in androgen independent prostate cancer cells , 2005, The Journal of Steroid Biochemistry and Molecular Biology.
[19] D. Feldman,et al. The development of androgen-independent prostate cancer , 2001, Nature Reviews Cancer.
[20] D. Tindall,et al. Mechanisms of androgen-refractory prostate cancer. , 2004, The New England journal of medicine.
[21] Carsten O. Daub,et al. pre-miRNA profiles obtained through application of locked nucleic acids and deep sequencing reveals complex 5′/3′ arm variation including concomitant cleavage and polyuridylation patterns , 2011, Nucleic acids research.
[22] Hsuan-Cheng Huang,et al. Androgen pathway stimulates MicroRNA‐216a transcription to suppress the tumor suppressor in lung cancer‐1 gene in early hepatocarcinogenesis , 2012, Hepatology.
[23] D. Bartel. MicroRNAs: Target Recognition and Regulatory Functions , 2009, Cell.
[24] H. Nakagama,et al. miR‐493 induction during carcinogenesis blocks metastatic settlement of colon cancer cells in liver , 2012, The EMBO journal.
[25] Andrey Golubov,et al. Alterations of microRNAs and their targets are associated with acquired resistance of MCF‐7 breast cancer cells to cisplatin , 2010, International journal of cancer.
[26] R. Dahiya,et al. Genistein Up-Regulates Tumor Suppressor MicroRNA-574-3p in Prostate Cancer , 2013, PloS one.
[27] C. Croce. Causes and consequences of microRNA dysregulation in cancer , 2009, Nature Reviews Genetics.
[28] Carlo M. Croce,et al. Causes and Consequences of MicroRNA Dysregulation , 2012, Cancer journal.
[29] P. Nelson,et al. Intraprostatic androgens and androgen-regulated gene expression persist after testosterone suppression: therapeutic implications for castration-resistant prostate cancer. , 2007, Cancer research.
[30] D. Dykxhoorn. MicroRNAs and metastasis: little RNAs go a long way. , 2010, Cancer research.
[31] Jihan Wang,et al. Aberrant expression of microRNAs in gastric cancer and biological significance of miR-574-3p. , 2012, International immunopharmacology.
[32] H. Scher,et al. Targeting the androgen receptor pathway in prostate cancer. , 2008, Current opinion in pharmacology.
[33] Judy Lieberman,et al. Dysregulation of microRNA biogenesis and gene silencing in cancer , 2015, Science Signaling.